CASH FLOW DISCLOSURES AND NON CASH INVESTING AND FINANCING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2022

Supplemental Cash Flow Elements [Abstract]

Schedule of Cash Flow

The following non-cash investing and financing activities occurred during the nine months ended September 30, 2022 and 2021:

	2022		2021
Issuance of share based payments	$	5,462	$	13,967
Accrued payables for capital expenditures placed into service	1,222		148
Adjustment to Record Noncontrolling Interest at Redemption Value	2,349		1,968

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2022 and 2021:

	2022		2021
Cash and cash equivalents	$	94,271	$	71,244
Escrowed cash	13,129		12,497
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	107,400	$	83,741

Summary of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2022 and 2021:

	2022		2021
Cash and cash equivalents	$	94,271	$	71,244
Escrowed cash	13,129		12,497
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	107,400	$	83,741